Alpha Cognition (Alpha Cognition) Price-to-Tangible-Book : (As of Jun. 10, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Alpha Cognition Price-to-Tangible-Book?

As of today (2024-06-10), Alpha Cognition's share price is $0.56935. Alpha Cognition's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was $-0.00. Hence, Alpha Cognition's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Alpha Cognition's Price-to-Tangible-Book or its related term are showing as below:

During the past 4 years, Alpha Cognition's highest Price to Tangible Book Ratio was 80.59. The lowest was 6.84. And the median was 14.37.

ACOGF's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.77
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Alpha Cognition's share price is $0.56935. Alpha Cognition's Book Value per Sharefor the quarter that ended in Mar. 2024 was $0.00. Hence, Alpha Cognition's P/B Ratio of today is .

Alpha Cognition Price-to-Tangible-Book Historical Data

The historical data trend for Alpha Cognition's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpha Cognition Price-to-Tangible-Book Chart

Alpha Cognition Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

8.05

Alpha Cognition Quarterly Data
	Jan20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial										20.63	-	-	-	-

Competitive Comparison of Alpha Cognition's Price-to-Tangible-Book

For the Biotechnology subindustry, Alpha Cognition's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alpha Cognition's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alpha Cognition's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Alpha Cognition's Price-to-Tangible-Book falls into.

Alpha Cognition Price-to-Tangible-Book Calculation

Alpha Cognition's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	0.56935	/	-0.002
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Alpha Cognition Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Alpha Cognition's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Alpha Cognition (Alpha Cognition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alpha Cognition Inc (OTCPK:ACOGF) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

ACOG:Canada

Address

301 - 1228 Hamilton Street, Vancouver, BC, CAN, V6B 6L2

Website

https://www.alphacognition.com

Alpha Cognition Inc is a clinical stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, and Cognitive Impairment with Mild Traumatic Brain Injury (mTBI) for which there are limited or no treatment options. The Company is focused on the development of ALPHA-1062 for the treatment of mild-to-moderate Alzheimer's disease and completed an NDA filing to the FDA in September 2023. The company anticipates an FDA approval in mid-2024. The Company's ALPHA-1062 development program is primarily focused on clinical and regulatory development, Chemistry, Manufacturing and Control (CMC) development, and commercial readiness.